MPO and myocardial infarction: Furthermore, in a mouse MI model, administration of PF-1355 (MPO inhibitor) for 7 days reduced inflammatory cell infiltration and attenuated left ventricular dilation, and MPO inhibition has been shown to improve ischemia-related cardiac remodeling in animal experiments (50).